CCR3 receptor antagonists (Abbott)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCCR3 receptor antagonists (Abbott)
Drug Alias NameA-122057A-122058
ClassificationSmall molecules
Mechanisms of ActionC-C chemokine receptor type 3 antagonistsEosinophil inhibitors
TargetsC-C chemokine receptor type 3
Therapy Area/IndicationsInflammationAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsInflammationAsthma

Other Information

ATC CodeN/A
Related LinksN/A